Bayer, Dewpoint Therapeutics Sign Deal for Heart-Disease Treatment

Bayer, Dewpoint Therapeutics Sign Deal for Heart-Disease Treatment

Source: 
Morningstar
snippet: 

Bayer and Dewpoint Therapeutics signed a deal to develop a treatment for people with heart-muscle disease, part of a previous collaborative pact between the two companies.